Christopher D Lao

Summary

Affiliation: University of Michigan
Country: USA

Publications

  1. ncbi request reprint Targeting events in melanoma carcinogenesis for the prevention of melanoma
    Christopher D Lao
    University of Michigan, 1500 East Medical Center DriveAnn Arbor, MI 48109 0848, USA
    Expert Rev Anticancer Ther 6:1559-68. 2006
  2. pmc Dose escalation of a curcuminoid formulation
    Christopher D Lao
    Division of Hematology Oncology, Department of Internal Medicine, University of Michigan, 2150 CCGC, Ann Arbor, MI 48109 0930, USA
    BMC Complement Altern Med 6:10. 2006
  3. doi request reprint Management options for metastatic melanoma in the era of novel therapies: a primer for the practicing dermatologist: part II: Management of stage IV disease
    Matthew C Fox
    Department of Dermatology, University of Michigan Medical School and Comprehensive Cancer Center, Ann Arbor, Michigan, USA
    J Am Acad Dermatol 68:13.e1-13; quiz 26-8. 2013
  4. doi request reprint Clinicopathologic features of primary Merkel cell carcinoma: a detailed descriptive analysis of a large contemporary cohort
    Jennifer L Schwartz
    Department of Dermatology, University of Michigan Health System, Ann Arbor, Michigan 48109, USA
    Dermatol Surg 39:1009-16. 2013
  5. doi request reprint Features predicting sentinel lymph node positivity in Merkel cell carcinoma
    Jennifer L Schwartz
    University of Michigan Health System, 1910 Taubman Center, 1500 E Medical Center Dr, Ann Arbor, MI 48109 0314, USA
    J Clin Oncol 29:1036-41. 2011
  6. doi request reprint Management options for metastatic melanoma in the era of novel therapies: a primer for the practicing dermatologist: part I: Management of stage III disease
    Matthew C Fox
    Department of Dermatology, University of Michigan Medical School and Comprehensive Cancer Center, Ann Arbor, Michigan, USA
    J Am Acad Dermatol 68:1.e1-9; quiz 10-12. 2013
  7. ncbi request reprint Irreversible ototoxicity associated with difluoromethylornithine
    Christopher D Lao
    Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, 48109, USA
    Cancer Epidemiol Biomarkers Prev 13:1250-2. 2004
  8. doi request reprint Molecular diagnostics of melanoma fine-needle aspirates: a cytology-histology correlation study
    Kurt D Bernacki
    Dept of Pathology, University of Michigan Medical School, 2G332 UH, 1500 E Medical Center Dr, Ann Arbor, MI 48109 5054, USA
    Am J Clin Pathol 138:670-7. 2012
  9. ncbi request reprint Dysplasia in Barrett esophagus
    Christopher D Lao
    Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan 48109, USA
    Cancer 100:1622-7. 2004
  10. ncbi request reprint Merkel cell carcinoma: critical review with guidelines for multidisciplinary management
    Christopher K Bichakjian
    Department of Dermatology, University of Michigan Health System, Ann Arbor, Michigan 48109 0314, USA
    Cancer 110:1-12. 2007

Research Grants

  1. Development of a Melanoma Chemoprevention Model
    CHRISTOPHER LAO; Fiscal Year: 2007

Collaborators

Detail Information

Publications13

  1. ncbi request reprint Targeting events in melanoma carcinogenesis for the prevention of melanoma
    Christopher D Lao
    University of Michigan, 1500 East Medical Center DriveAnn Arbor, MI 48109 0848, USA
    Expert Rev Anticancer Ther 6:1559-68. 2006
    ..We will review the data for several promising agents, including statins, curcumin, resveratrol, silymarin and green tea, and discuss some importance issues and concepts that should be considered in any melanoma chemoprevention strategy...
  2. pmc Dose escalation of a curcuminoid formulation
    Christopher D Lao
    Division of Hematology Oncology, Department of Internal Medicine, University of Michigan, 2150 CCGC, Ann Arbor, MI 48109 0930, USA
    BMC Complement Altern Med 6:10. 2006
    ..However, few systematic studies of curcumin's pharmacology and toxicology in humans have been performed...
  3. doi request reprint Management options for metastatic melanoma in the era of novel therapies: a primer for the practicing dermatologist: part II: Management of stage IV disease
    Matthew C Fox
    Department of Dermatology, University of Michigan Medical School and Comprehensive Cancer Center, Ann Arbor, Michigan, USA
    J Am Acad Dermatol 68:13.e1-13; quiz 26-8. 2013
    ..The approach to patients with brain metastases will be discussed, as will recommendations for distress screening and defining aspects of palliative care...
  4. doi request reprint Clinicopathologic features of primary Merkel cell carcinoma: a detailed descriptive analysis of a large contemporary cohort
    Jennifer L Schwartz
    Department of Dermatology, University of Michigan Health System, Ann Arbor, Michigan 48109, USA
    Dermatol Surg 39:1009-16. 2013
    ..Little uniformity exists in the clinical and histologic variables reported with primary Merkel cell carcinoma (MCC)...
  5. doi request reprint Features predicting sentinel lymph node positivity in Merkel cell carcinoma
    Jennifer L Schwartz
    University of Michigan Health System, 1910 Taubman Center, 1500 E Medical Center Dr, Ann Arbor, MI 48109 0314, USA
    J Clin Oncol 29:1036-41. 2011
    ..Merkel cell carcinoma (MCC) is a relatively rare, potentially aggressive cutaneous malignancy. We examined the clinical and histologic features of primary MCC that may correlate with the probability of a positive sentinel lymph node (SLN)...
  6. doi request reprint Management options for metastatic melanoma in the era of novel therapies: a primer for the practicing dermatologist: part I: Management of stage III disease
    Matthew C Fox
    Department of Dermatology, University of Michigan Medical School and Comprehensive Cancer Center, Ann Arbor, Michigan, USA
    J Am Acad Dermatol 68:1.e1-9; quiz 10-12. 2013
    ..Part II of this series will address stage IV disease...
  7. ncbi request reprint Irreversible ototoxicity associated with difluoromethylornithine
    Christopher D Lao
    Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, 48109, USA
    Cancer Epidemiol Biomarkers Prev 13:1250-2. 2004
    ..This is the first case reported of irreversible ototoxicity in a clinical trial participant receiving DFMO and, thus, trial participants should be made aware of this small but important risk...
  8. doi request reprint Molecular diagnostics of melanoma fine-needle aspirates: a cytology-histology correlation study
    Kurt D Bernacki
    Dept of Pathology, University of Michigan Medical School, 2G332 UH, 1500 E Medical Center Dr, Ann Arbor, MI 48109 5054, USA
    Am J Clin Pathol 138:670-7. 2012
    ..Thus, melanoma FNA for molecular diagnostics represents a rapid, minimally invasive, and effective management strategy in this era of precision medicine...
  9. ncbi request reprint Dysplasia in Barrett esophagus
    Christopher D Lao
    Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan 48109, USA
    Cancer 100:1622-7. 2004
    ..The objective of the current study was to more accurately determine the prevalence of dysplasia among individuals with Barrett esophagus who would be available for enrollment in a chemoprevention trial...
  10. ncbi request reprint Merkel cell carcinoma: critical review with guidelines for multidisciplinary management
    Christopher K Bichakjian
    Department of Dermatology, University of Michigan Health System, Ann Arbor, Michigan 48109 0314, USA
    Cancer 110:1-12. 2007
    ..Finally, the authors have provided treatment guidelines based on the available evidence and their multidisciplinary experience...
  11. ncbi request reprint Strategies for prevention of colorectal cancer: pharmaceutical and nutritional interventions
    Christopher D Lao
    University of Michigan, 2150 Cancer Center and Geriatrics Center, Ann Arbor, MI 48109 USA
    Curr Treat Options Oncol 5:417-26. 2004
    ....
  12. ncbi request reprint Case 19-2008: Merkel-cell carcinoma
    Sandra L Wong
    N Engl J Med 359:1630; author reply 1630-1. 2008

Research Grants2

  1. Development of a Melanoma Chemoprevention Model
    CHRISTOPHER LAO; Fiscal Year: 2007
    ..This line of investigation will help determine the importance of NF-kB and 12-LOX in melanoma carcinogenesis and provide an infrastructure for rapid testing of putative Chemoprevention agents and biomarkers in the future. ..